Get the Stockscreener App
0.8769
9.60%
-0.0931
After Hours:
.89
0.0131
+1.49%
Sutro Biopharma Inc stock is traded at $0.8769, with a volume of 529.09K.
It is down -9.60% in the last 24 hours and up +11.89% over the past month.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
See More
Previous Close:
$0.97
Open:
$0.9479
24h Volume:
529.09K
Relative Volume:
0.71
Market Cap:
$74.34M
Revenue:
$153.73M
Net Income/Loss:
$-106.79M
P/E Ratio:
-0.4926
EPS:
-1.78
Net Cash Flow:
$-115.93M
1W Performance:
-17.27%
1M Performance:
+11.89%
6M Performance:
-34.56%
1Y Performance:
-80.29%
1-Day Range:
$0.8546
$0.96
1-Week Range:
$0.8546
$1.03
52-Week Range:
$0.5231
$4.80
Sutro Biopharma Inc Stock (STRO) Company Profile
Name
Sutro Biopharma Inc
Sector
Industry
Phone
650-392-8412
Address
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Compare STRO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.8769 | 77.18M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-17-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-14-25 | Downgrade | BofA Securities | Buy → Underperform |
| Mar-14-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Mar-14-25 | Downgrade | Wedbush | Outperform → Neutral |
| May-08-24 | Initiated | BofA Securities | Buy |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-06-23 | Initiated | Oppenheimer | Outperform |
| Mar-21-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-18-22 | Resumed | Wells Fargo | Overweight |
| Jun-18-21 | Initiated | H.C. Wainwright | Buy |
| Dec-03-20 | Initiated | Stifel | Buy |
| Sep-02-20 | Initiated | Jefferies | Buy |
| Jul-16-20 | Initiated | Wells Fargo | Overweight |
| Jan-13-20 | Initiated | SunTrust | Buy |
| Oct-07-19 | Initiated | BTIG Research | Buy |
| Jul-18-19 | Initiated | Deutsche Bank | Buy |
| Apr-29-19 | Initiated | H.C. Wainwright | Buy |
| Oct-22-18 | Initiated | JMP Securities | Mkt Outperform |
| Oct-22-18 | Initiated | Piper Jaffray | Overweight |
| Oct-22-18 | Initiated | Wedbush | Outperform |
View All
Sutro Biopharma Inc Stock (STRO) Latest News
Sutro Biopharma (NASDAQ:STRO) Upgraded at Wall Street Zen - Defense World
Trend analysis for Sutro Biopharma Inc. this weekWeekly Investment Recap & Reliable Breakout Forecasts - Newser
Chart based exit strategy for Sutro Biopharma Inc.Weekly Stock Analysis & Short-Term Trading Alerts - Newser
Using economic indicators to assess Sutro Biopharma Inc. potentialEarnings Overview Summary & Low Volatility Stock Suggestions - Newser
Does Sutro Biopharma Inc. qualify in momentum factor screeningWeekly Trend Recap & Technical Analysis for Trade Confirmation - Newser
Risk vs reward if holding onto Sutro Biopharma Inc.IPO Watch & Low Drawdown Investment Strategies - Newser
Is Sutro Biopharma Inc. still worth holding after the dipMarket Rally & Weekly Stock Performance Updates - Newser
What’s the recovery path for long term holders of Sutro Biopharma Inc.July 2025 Weekly Recap & Expert Curated Trade Ideas - Newser
Using data tools to time your Sutro Biopharma Inc. exitQuarterly Trade Report & Smart Swing Trading Techniques - Newser
Measuring Sutro Biopharma Inc.’s beta against major indicesQuarterly Portfolio Summary & Community Consensus Trade Alerts - Newser
What indicators show strength in Sutro Biopharma Inc.Portfolio Gains Summary & Smart Allocation Stock Reports - Newser
What the charts say about Sutro Biopharma Inc. today2025 Trading Volume Trends & Risk Managed Trade Strategies - Newser
Nuveen LLC Buys New Holdings in Sutro Biopharma, Inc. $STRO - MarketBeat
How to forecast Sutro Biopharma Inc. trends using time seriesWeekly Trade Recap & Daily Profit Maximizing Trade Tips - Newser
Assets Of Sutro Biopharma To Be Auctioned – December 2025 - Bioprocess Online
Using fundamentals and technicals on Sutro Biopharma Inc.Portfolio Value Report & Growth Focused Entry Reports - Newser
Sutro Biopharma Inc. stock daily chart insights2025 Volatility Report & Smart Money Movement Alerts - Newser
Market reaction to Sutro Biopharma Inc.’s recent newsQuarterly Profit Review & Proven Capital Preservation Tips - Newser
Can you recover from losses in Sutro Biopharma Inc.Weekly Trading Summary & Community Verified Trade Signals - Newser
Published on: 2025-09-10 02:17:40 - Newser
Relative strength of Sutro Biopharma Inc. in sector analysisQuarterly Portfolio Review & Reliable Volume Spike Trade Alerts - Newser
Volume spikes in Sutro Biopharma Inc. stock – what they mean2025 Macro Impact & AI Powered Market Trend Analysis - Newser
relative strength of sutro biopharma inc. in sector analysis2025 Price Action Summary & Verified Technical Signals - Newser
Ranking Sutro Biopharma Inc. among high performing stocks via toolsJuly 2025 Selloffs & Short-Term High Return Ideas - Newser
Using data filters to optimize entry into Sutro Biopharma Inc.Trade Analysis Report & Reliable Entry Point Trade Alerts - Newser
Is Sutro Biopharma Inc. in a bullish channel2025 Retail Activity & Fast Gaining Stock Strategy Reports - Lancaster City Council
Using AI based signals to follow Sutro Biopharma Inc.Weekly Risk Summary & AI Enhanced Trading Signals - Newser
What machine learning models say about Sutro Biopharma Inc.Weekly Earnings Recap & Verified Short-Term Plans - Newser
Price action breakdown for Sutro Biopharma Inc.CPI Data & Weekly Return Optimization Plans - Newser
Fibonacci Support Holding Strong in Sutro Biopharma Inc.Market Growth Report & Technical Confirmation Trade Alerts - beatles.ru
Sutro Biopharma Inc. Pullback Analyzed — Is It Time to Exit2025 Volume Leaders & Daily Stock Momentum Reports - beatles.ru
Reversal Confirmed Sutro Biopharma Inc. Stock Rallies Above MA2025 Investor Takeaways & Fast Entry High Yield Tips - beatles.ru
Reversal indicators forming on Sutro Biopharma Inc. stock2025 Biggest Moves & Free Reliable Trade Execution Plans - Newser
AI Indicators Detect Buy Opportunity in Sutro Biopharma Inc.2025 Trade Ideas & High Yield Equity Trading Tips - beatles.ru
Sutro Biopharma Inc Stock (STRO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):